New Publication – Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings.
ABIGO Medical are very proud to report the recent publication from the Pasteur Institute in Paris regarding the binding capabilities of Sorbact. The study is titled:
The bacteria Mycobacterium ulcerans is responsible for the formation of the Buruli ulcer, a disease process that results in a high morbidity and economic impost across sub-Saharan Africa and many third world countries. This study supports the well documented bacteria binding capability of the Sorbact technology, furthermore, the study will lead into future clinical trials aimed at assisting management of patients suffering from Buruli ulcer disease.
The focus of ABIGO Medical is to help alleviate the heavy burden placed on antibiotics through both infection prevention measures and in the assisted management of wounds like the Buruli ulcer. We are very optimistic these findings will promote further high quality clinical research into this and similar areas of medicine.